
  
    
      
        Background_NNP
        Breast_NNP cancer_NN is_VBZ the_DT most_RBS common_JJ cancer_NN (_( excluding_VBG
        non-malignant_JJ skin_NN melanomas_NNS )_) and_CC the_DT second_JJ leading_VBG cause_NN
        of_IN cancer_NN deaths_NNS among_IN women_NNS in_IN the_DT US_NNP [_NN 1_CD ]_NN ._. During_IN the_DT
        1990_CD s_VBZ ,_, the_DT observed_VBN incidence_NN of_IN female_JJ breast_NN cancers_NNS
        increased_VBN ,_, and_CC was_VBD accompanied_VBN by_IN a_DT significant_JJ decrease_NN in_IN
        breast_NN cancer_NN mortality_NN [_NN 2_CD ]_NN ._. Both_DT trends_NNS may_MD be_VB due_JJ ,_, in_IN
        part_NN ,_, to_TO the_DT increased_VBN utilization_NN of_IN mammography_NN [_NN 3_CD ]_NN ._.
        From_IN 1989_CD to_TO 1997_CD ,_, the_DT percentage_NN of_IN women_NNS aged_VBN =_SYM 40_CD years_NNS
        who_WP reported_VBD "_'' ever_RB had_VBD a_DT mammogram_NN "_'' increased_VBN from_IN 63_CD ._. 9_CD %_NN to_TO
        84_CD ._. 8_CD %_NN [_NN 3_CD 4_CD ]_NN ._. However_RB ,_, there_EX was_VBD a_DT substantial_JJ difference_NN
        between_IN those_DT who_WP were_VBD ever_RB screened_VBD and_CC the_DT proportion_NN of_IN
        women_NNS screened_VBD in_IN the_DT previous_JJ 2_CD years_NNS (_( 84_CD ._. 8_CD %_NN v_NN ._. 71_CD ._. 3_LS %_NN
        [_NN 1997_CD ]_NN )_) [_NN 4_CD ]_NN ._.
        Relative_NNP to_TO areas_NNS of_IN higher_JJR population_NN density_NN ,_, areas_NNS of_IN
        lower_JJR population_NN density_NN have_VBP been_VBN noted_VBN to_TO have_VB increased_VBN
        breast_NN cancer_NN incidence_NN [_NN 5_CD ]_NN and_CC breast_NN cancer_NN mortality_NN [_NN
        6_CD ]_NN ._. Rural_NNP women_NNS were_VBD also_RB less_RBR likely_JJ than_IN their_PRP$ urban_JJ
        counterparts_NNS to_TO have_VB received_VBN a_DT mammogram_NN [_NN 7_CD ]_NN ._. This_DT
        difference_NN was_VBD attributable_JJ to_TO disparities_NNS in_IN education_NN
        level_NN ,_, household_NN income_NN ,_, and_CC health_NN insurance_NN coverage_NN ._.
        Rural_JJ women_NNS were_VBD also_RB less_RBR likely_JJ than_IN urban_JJ women_NNS to_TO have_VB
        a_DT recent_JJ mammogram_NN or_CC clinical_JJ breast_NN exam_NN (_( CBE_NNP )_) [_NN 8_CD ]_NN ._.
        Conversely_RB ,_, a_DT recent_JJ qualitative_JJ study_NN reported_VBD that_IN rural_JJ
        women_NNS had_VBD higher_JJR rates_NNS of_IN mammography_NN and_CC CBE_NNP than_IN their_PRP$
        urban_JJ and_CC suburban_JJ counterparts_NNS [_NN 9_CD ]_NN ._.
        Providers_NNP of_IN primary_JJ care_NN services_NNS play_VBP a_DT critical_JJ role_NN
        in_IN determining_VBG patient_NN compliance_NN with_IN preventive_JJ services_NNS
        through_IN direct_JJ recommendations_NNS to_TO their_PRP$ patients_NNS [_NN 10_CD 11_CD 12_CD
        ]_NN ._. Women_NNP who_WP were_VBD "_'' off_IN schedule_NN "_'' for_IN regular_JJ mammograms_NNS
        were_VBD significantly_RB less_RBR likely_JJ to_TO have_VB a_DT regular_JJ physician_NN
        and_CC to_TO have_VB received_VBN a_DT physician_NN recommendation_NN for_IN a_DT
        mammogram_NN than_IN "_'' on_IN schedule_NN "_'' women_NNS [_NN 13_CD ]_NN ._. Another_DT study_NN
        of_IN family_NN physicians_NNS and_CC general_JJ internists_NNS showed_VBD that_IN 70_CD %_NN
        of_IN women_NNS who_WP received_VBD a_DT provider_NN referral_NN completed_VBD a_DT
        screening_NN mammography_NN within_IN one_CD year_NN versus_CC only_RB 18_CD %_NN of_IN
        self-referred_JJ women_NNS [_NN 12_CD ]_NN ._. Over_IN 90_CD %_NN of_IN rural_JJ women_NNS report_VBP
        that_IN a_DT doctor_NN 's_POS recommendation_NN to_TO have_VB breast_NN cancer_NN
        screening_NN is_VBZ "_'' important_JJ "_'' [_NN 14_CD ]_NN ._.
        In_IN the_DT American_NNP Cancer_NNP Society_NNP 's_POS second_JJ survey_NN of_IN
        physician_NN attitudes_NNS and_CC practices_NNS in_IN early_JJ cancer_NN
        detection_NN ,_, physicians_NNS reported_VBD that_IN screening_NN guidelines_NNS
        influenced_VBD their_PRP$ referrals_NNS for_IN mammograms_NNS [_NN 15_CD ]_NN ._. It_PRP
        should_MD be_VB noted_VBN that_IN multiple_JJ factors_NNS contribute_VBP to_TO
        clinician_NN compliance_NN with_IN guidelines_NNS including_VBG :_:
        provider-related_JJ ,_, guideline-related_JJ ,_, patient-related_JJ ,_, and_CC
        environment-related_JJ variables_NNS [_NN 16_CD ]_NN ._. Our_PRP$ study_NN examined_VBD
        geographic_JJ location_NN of_IN practice_NN to_TO identify_VB any_DT variations_NNS
        in_IN approaches_NNS to_TO breast_NN cancer_NN screening_NN among_IN clinicians_NNS
        (_( physicians_NNS ,_, nurse_NN practitioners_NNS ,_, and_CC physician_NN assistants_NNS )_)
        in_IN primary_JJ care_NN settings_NNS ._.
      
      
        Methods_NNP
        Comprehensive_JJ surveys_NNS examining_VBG issue_NN of_IN cancer_NN
        prevention_NN and_CC control_NN were_VBD mailed_VBN to_TO primary_JJ care_NN
        physicians_NNS ,_, nurse_NN practitioners_NNS ,_, and_CC physician_NN assistants_NNS
        (_( n_NN =_SYM 1761_CD )_) in_IN an_DT 8_CD county_NN region_NN of_IN Western_NNP New_NNP York_NNP ._.
        Primary_JJ care_NN physicians_NNS included_VBD family_NN physicians_NNS ,_, general_JJ
        practitioners_NNS ,_, general_JJ internists_NNS ,_, and_CC
        obstetricians_NNS /_NN gynaecologists_NNS ._. Mailing_NNP addresses_NNS were_VBD
        obtained_VBN from_IN the_DT provider_NN directories_NNS of_IN a_DT major_JJ regional_JJ
        health_NN maintenance_NN organization_NN (_( HMO_NNP )_) ,_, supplemented_JJ with_IN
        mailing_NN lists_NNS from_IN the_DT Nurse_NNP Practitioner_NNP Association_NNP of_IN
        Western_NNP New_NNP York_NNP (_( NPWNY_NNP )_) ,_, and_CC the_DT Western_NNP New_NNP York_NNP
        Physician_NN Assistants_NNP '_POS Association_NNP (_( WNYPAA_NNP )_) ._. Western_NNP New_NNP
        York_NNP ranks_NNS among_IN the_DT top_JJ communities_NNS in_IN the_DT US_NNP for_IN Health_NNP
        Maintenance_NNP Organization_NNP (_( HMO_NNP )_) penetrance_NN ._. For_IN this_DT reason_NN ,_,
        essentially_RB all_DT primary_JJ care_NN providers_NNS are_VBP included_VBN in_IN HMO_NNP
        practitioner_NN mailing_NN lists_NNS (_( 96_CD %_NN -_: confirm_VB this_DT figure_NN )_) ._.
        An_DT initial_JJ mailing_NN to_TO primary_JJ care_NN physicians_NNS and_CC
        non-physician_JJ providers_NNS (_( nurse_NN practitioners_NNS and_CC physician_NN
        assistants_NNS )_) was_VBD performed_VBN in_IN February_NNP 2001_CD ,_, followed_VBN by_IN two_CD
        additional_JJ mailings_NNS to_TO non-respondents_JJ at_IN 4_CD -_: week_NN intervals_NNS ._.
        The_DT first_JJ follow_VB up_RB mailing_NN was_VBD the_DT same_JJ as_IN the_DT initial_JJ
        mailing_NN and_CC included_VBD an_DT additional_JJ copy_NN of_IN the_DT
        questionnaire_NN ._. The_DT third_JJ mailing_NN was_VBD a_DT postcard_NN reminding_VBG
        clinicians_NNS to_TO return_VB their_PRP$ surveys_NNS ._.
        The_DT survey_NN consisted_VBD of_IN 22_CD items_NNS eliciting_VBG information_NN
        on_IN clinician_NN knowledge_NN ,_, attitudes_NNS ,_, and_CC behaviours_NNS
        concerning_VBG the_DT delivery_NN of_IN general_JJ preventive_JJ and_CC cancer_NN
        screening_NN services_NNS ,_, as_RB well_RB as_IN personal_JJ and_CC professional_JJ
        demographic_JJ information_NN ._. The_DT survey_NN was_VBD pre-tested_VBN for_IN
        content_NN validity_NN using_VBG a_DT convenience_NN sample_NN of_IN health_NN care_NN
        clinicians_NNS ._.
        Responses_NNS to_TO four_CD multiple-choice_JJ items_NNS were_VBD used_VBN to_TO
        examine_VB variation_NN in_IN breast_NN cancer_NN screening_NN practices_NNS :_:
        
        1_LS ._. At_IN what_WP age_NN should_MD an_DT average-risk_JJ
        woman_NN initiate_NN screening_NN for_IN breast_NN cancer_NN using_VBG clinical_JJ
        breast_NN examination_NN ?_. [_NN accepted_VBD answer_NN :_: 20_CD years_NNS ]_NN [_NN 15_CD ]_NN
        ._.
        
        2_LS ._. At_IN what_WP age_NN should_MD an_DT average-risk_JJ
        woman_NN get_VBP a_DT baseline_NN mammogram_NN ?_. [_NN accepted_VBD answer_NN :_: 35_CD
        years_NNS ]_NN ._. No_DT current_JJ guidelines_NNS address_VBP this_DT item_NN ,_, although_IN
        it_PRP was_VBD a_DT prior_JJ recommendation_NN of_IN ACS_NNP ,_, it_PRP is_VBZ not_RB addressed_VBN
        in_IN their_PRP$ current_JJ guidelines_NNS ._.
        
        3_LS ._. At_IN what_WP age_NN should_MD an_DT average-risk_JJ
        woman_NN begin_VB having_VBG mammograms_NNS every_DT 1_CD -_: 2_CD
        years_NNS ?_. [_NN accepted_VBD answer_NN :_: 40_CD years_NNS ]_NN [_NN 15_CD 17_CD 18_CD 19_CD ]_NN
        ._.
        
        4_LS ._. At_IN what_WP age_NN should_MD an_DT average-risk_JJ
        woman_NN begin_VB yearly_JJ mammograms_NNS ?_. [_NN accepted_VBD answer_NN :_: 50_CD
        years_NNS ]_NN [_NN 15_CD 17_CD 18_CD ]_NN ._.
        Since_IN no_DT single_JJ organization_NN has_VBZ issued_VBN breast_NN cancer_NN
        screening_NN guidelines_NNS ,_, which_WDT address_VBP all_DT of_IN the_DT four_CD
        screening_NN items_NNS ,_, we_PRP relied_VBD upon_IN guidelines_NNS issued_VBN by_IN
        several_JJ different_JJ organizations_NNS ._. For_IN example_NN ,_, the_DT American_NNP
        Academy_NNP of_IN Family_NNP Physicians_NNPS [_NN 18_CD 20_CD ]_NN and_CC the_DT 2_CD ndUnited_JJ
        States_NNPS Preventive_NNP Services_NNPS Task_NNP Force_NNP (_( USPSTF_NNP )_) advise_VB
        mammography_NN every_DT 1_CD -_: 2_CD years_NNS for_IN women_NNS aged_VBN 50_CD -_: 69_CD years_NNS [_NN 21_CD
        ]_NN ._. (_( Since_IN completion_NN of_IN data_NNS collection_NN for_IN this_DT project_NN ,_,
        the_DT 3_CD rd_NN USPSTF_NNP released_VBD an_DT updated_VBN statement_NN advising_VBG
        mammography_NN ,_, with_IN or_CC without_IN clinical_JJ breast_NN examination_NN ,_,
        every_DT 1_CD -_: 2_CD years_NNS for_IN women_NNS aged_VBN 40_CD years_NNS and_CC older_JJR [_NN 22_CD ]_NN
        )_) ._.
        A_DT summary_NN index_NN of_IN beliefs_NNS about_IN breast_NN cancer_NN screening_NN
        was_VBD created_VBN by_IN summing_VBG the_DT total_JJ number_NN of_IN responses_NNS in_IN
        agreement_NN with_IN these_DT items_NNS ;_: values_NNS for_IN this_DT summary_NN
        variable_NN ranged_VBD between_IN zero_CD and_CC four_CD ._. It_PRP is_VBZ important_JJ to_TO
        emphasize_VB that_IN the_DT focus_NN is_VBZ not_RB on_IN "_'' correct_JJ "_'' versus_CC
        "_'' incorrect_JJ "_'' responses_NNS ,_, but_CC rather_RB the_DT variations_NNS among_IN
        respondents_NNS ._. For_IN example_NN ,_, if_IN a_DT large_JJ proportion_NN of_IN
        respondents_NNS indicate_VBP the_DT same_JJ response_NN to_TO an_DT item_NN (_( s_VBZ )_) this_DT
        would_MD indicate_VB limited_JJ variation_NN ._.
        Demographic_NNP information_NN collected_VBN on_IN respondents_NNS
        included_VBD clinician_NN age_NN ,_, gender_NN ,_, race_NN /_NN ethnicity_NN ,_,
        professional_JJ groups_NNS ,_, board_NN certification_NN ,_, specialty_NN ,_,
        practice_NN structure_NN ,_, work_NN schedule_NN ,_, involvement_NN with_IN
        supervision_NN of_IN trainees_NNS ,_, and_CC the_DT zip_NN code_NN location_NN of_IN their_PRP$
        clinical_JJ practice_NN ._.
        Using_VBG 2000_CD United_NNP States_NNPS (_( US_NNP )_) Census_NNP figures_NNS and_CC
        geographic_JJ land_NN area_NN (_( in_IN square_JJ miles_NNS )_) ,_, the_DT population_NN
        density_NN of_IN each_DT zip_NN code_NN area_NN in_IN Western_NNP New_NNP York_NNP was_VBD
        determined_VBN (_( population_NN /_NN square_JJ mile_NN )_) ._. Calculated_VBN population_NN
        densities_NNS were_VBD matched_VBN with_IN the_DT clinical_JJ practice_NN site_NN zip_NN
        codes_NNS provided_VBN by_IN survey_NN respondents_NNS ._. Practice_NNP site_NN zip_NN
        codes_NNS were_VBD then_RB divided_VBN into_IN urban_JJ ,_, rural_JJ ,_, and_CC suburban_JJ
        categories_NNS ._. The_DT analysis_NN is_VBZ based_VBN on_IN the_DT location_NN of_IN each_DT
        medical_JJ practice_NN and_CC not_RB on_IN the_DT residence_NN of_IN the_DT clinician_NN
        or_CC patients_NNS ._.
        All_DT zip_NN codes_NNS identified_VBN within_IN the_DT major_JJ cities_NNS of_IN WNY_NNP ,_,
        Buffalo_NNP or_CC Niagara_NNP Falls_NNP were_VBD categorized_VBN as_IN "_'' urban_JJ ._. "_'' Each_DT
        of_IN these_DT urban_JJ areas_NNS had_VBD population_NN densities_NNS exceeding_VBG
        1000_CD persons_NNS /_NN square_JJ mile_NN (_( persons_NNS /_NN mile_NN 2_LS )_) ._. Communities_NNP
        surrounding_VBG Buffalo_NNP and_CC Niagara_NNP Falls_NNP were_VBD identified_VBN as_IN
        "_'' suburban_JJ "_'' if_IN they_PRP were_VBD contiguous_JJ to_TO these_DT major_JJ cities_NNS
        and_CC had_VBD population_NN densities_NNS between_IN 500_CD -_: 1000_CD persons_NNS /_NN mile_NN
        2_CD ._. Although_IN five_CD zip_NN code_NN areas_NNS in_IN Erie_NNP and_CC Niagara_NNP
        Counties_NNP had_VBD population_NN densities_NNS exceeding_VBG 1000_CD
        persons_NNS /_NN mile_NN 2_CD (_( Hamburg_NNP [_NN 1050_CD ._. 4_LS /_NN mile_NN 2_CD ]_NN ,_, East_NNP Amherst_NNP
        [_NN 1068_CD ._. 5_LS /_NN mile_NN 2_CD ]_NN ,_, North_NNP Tonawanda_NNP [_NN 1222_CD ._. 5_LS /_NN mile_NN 2_CD ]_NN ,_, Tonawanda_NNP
        [_NN 3027_CD ._. 8_CD /_NN mile_NN 2_CD ]_NN ,_, and_CC Depew_NNP [_NN 3269_CD ._. 1_LS /_NN mile_NN 2_CD ]_NN )_) ,_, they_PRP were_VBD
        classified_VBN as_IN suburban_JJ areas_NNS for_IN this_DT study_NN ._. These_DT areas_NNS
        are_VBP distinctly_RB separate_JJ from_IN the_DT urban_JJ centers_NNS ,_, moreover_RB
        these_DT communities_NNS have_VBP higher_JJR socio-economic_JJ status_NN and_CC are_VBP
        not_RB burdened_VBN with_IN the_DT problems_NNS often_RB associated_VBN with_IN urban_JJ
        areas_NNS ._. Based_VBN on_IN these_DT changes_NNS ,_, 17_CD clinicians_NNS were_VBD
        reclassified_VBD (_( 4_CD %_NN ,_, 17_CD /_NN 428_CD )_) ._.
        The_DT remaining_VBG zip_NN code_NN areas_NNS were_VBD categorized_VBN as_IN "_'' rural_JJ "_''
        if_IN their_PRP$ population_NN density_NN was_VBD less_JJR than_IN 500_CD persons_NNS /_NN mile_NN
        2_CD ._. The_DT majority_NN of_IN these_DT communities_NNS are_VBP considered_VBN rural_JJ
        areas_NNS of_IN Western_NNP New_NNP York_NNP (_( WNY_NNP )_) by_IN local_JJ opinion_NN ._. However_RB ,_,
        communities_NNS with_IN total_JJ populations_NNS of_IN 2500_CD persons_NNS or_CC more_JJR
        were_VBD classified_VBN as_IN "_'' suburban_JJ "_'' consistent_JJ with_IN US_NNP Census_NNP
        criteria_NNS ._. This_DT re-classification_JJ impacted_VBN Fredonia_NNP (_( total_JJ
        population_NN 10706_CD )_) ,_, Olean_NNP (_( 20976_CD )_) ,_, Batavia_NNP (_( 22924_CD )_) ,_, Clarence_NNP
        (_( 8391_CD )_) ,_, Lockport_NNP (_( 48859_CD )_) ,_, Jamestown_NNP (_( 49478_CD )_) ,_, and_CC Lewiston_NNP
        (_( 12104_CD )_) ;_: #_# #_# of_IN clinician_NN were_VBD reclassified_VBD ._. Overall_RB ,_, this_DT
        process_NN resulted_VBD in_IN 59_CD %_NN of_IN respondents_NNS classified_VBN as_IN urban_JJ ,_,
        18_CD %_NN as_IN suburban_JJ and_CC 23_CD %_NN as_IN rural_JJ ._.
        Chi-square_NNP statistics_NNS were_VBD used_VBN to_TO compare_VB demographic_JJ
        and_CC professional_JJ characteristics_NNS of_IN respondents_NNS between_IN the_DT
        geographic_JJ categories_NNS ._. Chi-square_NNP analysis_NN was_VBD also_RB
        utilized_JJ to_TO assess_VB associations_NNS between_IN responses_NNS to_TO breast_NN
        cancer_NN screening_NN items_NNS with_IN independent_JJ variables_NNS such_JJ as_IN
        specialty_NN group_NN and_CC demographic_JJ characteristics_NNS (_( age_NN
        category_NN ,_, gender_NN ,_, etc_FW ._. )_) ._. Nonparametric_NNP tests_NNS were_VBD used_VBN to_TO
        evaluate_VB differences_NNS in_IN age_NN and_CC the_DT reported_VBN number_NN of_IN
        hours_NNS of_IN continuing_VBG medical_JJ education_NN credits_NNS (_( CME_NNP )_) as_IN
        these_DT variables_NNS were_VBD not_RB normally_RB distributed_VBN ._. Odds_NNS ratios_NNS
        (_( with_IN 95_CD %_NN confidence_NN intervals_NNS )_) were_VBD used_VBN to_TO compare_VB
        summary_NN scores_NNS for_IN breast_NN cancer_NN screening_NN and_CC utilization_NN
        of_IN breast_NN cancer_NN screening_NN guidelines_NNS among_IN respondents_NNS
        within_IN geographic_JJ categories_NNS ._. In_IN addition_NN ,_, we_PRP used_VBD a_DT
        multivariate_NN logistic_JJ regression_NN model_NN to_TO test_VB whether_IN
        geographic_JJ category_NN represented_VBD an_DT independent_JJ predictor_NN of_IN
        the_DT summary_NN score_NN for_IN breast_NN cancer_NN screening_NN and_CC use_NN of_IN
        written_VBN screening_NN guidelines_NNS ._. Results_NNS are_VBP presented_VBN as_IN
        adjusted_VBN odds_NNS ratios_NNS and_CC 95_CD %_NN confidence_NN intervals_NNS ._. SPSS_NNP
        10_CD ._. 1_LS software_NN (_( SPSS_NNP ,_, Inc_NNP ._. Chicago_NNP ,_, Ill_NNP ._. )_) was_VBD used_VBN for_IN the_DT
        analyses_NNS ._.
      
      
        Results_NNS
        Completed_NNP surveys_NNS were_VBD returned_VBN by_IN 469_CD clinicians_NNS ,_,
        yielding_VBG an_DT overall_JJ response_NN rate_NN of_IN 30_CD %_NN (_( n_NN =_SYM 469_CD /_NN 1582_CD )_) ;_:
        179_CD surveys_NNS could_MD not_RB be_VB delivered_VBN ._. Nurse_NNP practitioners_NNS had_VBD
        a_DT response_NN rate_NN of_IN 47_CD %_NN (_( n_NN =_SYM 199_CD /_NN 424_CD )_) ,_, which_WDT was_VBD
        significantly_RB greater_JJR than_IN that_DT of_IN primary_JJ care_NN physicians_NNS
        (_( 22_CD %_NN ,_, n_NN =_SYM 202_CD /_NN 905_CD )_) and_CC physician_NN assistants_NNS (_( 27_CD %_NN ,_, n_NN =_SYM
        68_CD /_NN 253_CD )_) ._. Of_IN these_DT 469_CD respondents_NNS ,_, the_DT following_VBG
        respondents_NNS were_VBD excluded_VBN from_IN analysis_NN :_:
        1_LS ._. Persons_NNP reporting_VBG their_PRP$ clinical_JJ practice_NN site_NN
        outside_IN of_IN WNY_NNP (_( n_NN =_SYM 9_CD )_) ;_:
        2_LS ._. Persons_NNP reporting_VBG less_JJR than_IN one_CD year_NN in_IN clinical_JJ
        practice_NN (_( n_NN =_SYM 26_CD )_) ;_:
        3_LS ._. Persons_NNP who_WP did_VBD not_RB self-identify_JJ as_IN
        "_'' residents_NNS "_'' /_NN "_'' trainees_NNS "_'' ,_, but_CC reported_VBD that_IN they_PRP were_VBD neither_DT
        "_'' board-eligible_JJ "_'' nor_CC "_'' board-certified_JJ "_'' (_( n_NN =_SYM 1_LS )_) ;_:
        4_LS ._. Persons_NNP who_WP did_VBD not_RB report_VB a_DT practice_NN site_NN zip_NN code_NN
        (_( n_NN =_SYM 5_LS )_) ._.
        Thus_RB ,_, analyses_NNS were_VBD based_VBN upon_IN responses_NNS from_IN 428_CD
        practitioners_NNS :_: 179_CD physicians_NNS ,_, 185_CD nurse_NN practitioners_NNS ,_, and_CC
        64_CD physician_NN assistants_NNS ._. The_DT majority_NN of_IN respondents_NNS
        reported_VBD practicing_VBG in_IN urban_JJ areas_NNS (_( 59_CD %_NN )_) ,_, with_IN a_DT relatively_RB
        equal_JJ distribution_NN of_IN respondents_NNS practicing_VBG in_IN rural_JJ and_CC
        suburban_JJ areas_NNS (_( 23_CD %_NN and_CC 18_CD %_NN respectively_RB )_) ._.
        As_IN summarized_VBD in_IN Table_NNP 1_CD ,_, the_DT suburban_JJ and_CC urban_JJ
        respondents_NNS were_VBD more_RBR likely_JJ to_TO be_VB female_JJ ._. Respondents_NNP did_VBD
        not_RB differ_VB by_IN age_NN or_CC race_NN ._. Rural_JJ respondents_NNS were_VBD more_RBR
        likely_JJ to_TO be_VB physicians_NNS (_( 54_CD %_NN )_) ,_, whereas_IN a_DT large_JJ proportion_NN
        of_IN both_DT suburban_JJ and_CC urban_JJ respondents_NNS were_VBD either_CC NPs_NNP or_CC
        PAs_NNP ._. Also_RB ,_, more_RBR rural_JJ practitioners_NNS were_VBD board-certified_JJ
        (_( 78_CD %_NN )_) compared_VBN to_TO suburban_JJ and_CC urban_JJ practitioners_NNS (_( 59_CD %_NN and_CC
        60_CD %_NN respectively_RB )_) ._. Urban_NNP practitioners_NNS were_VBD more_RBR likely_JJ to_TO
        report_VB being_VBG involved_VBN in_IN the_DT supervision_NN of_IN trainees_NNS (_( 69_CD %_NN )_) ._.
        Among_IN physician_NN respondents_NNS ,_, family_NN physicians_NNS or_CC general_JJ
        practitioners_NNS were_VBD more_RBR likely_JJ to_TO be_VB located_VBN in_IN rural_JJ areas_NNS
        (_( 76_CD %_NN )_) ._.
        Figure_NN 1_CD summarizes_NNS responses_NNS to_TO each_DT of_IN the_DT individual_JJ
        breast_NN cancer_NN screening_NN questions_NNS ._. Agreement_NNP with_IN "_'' correct_JJ "_''
        responses_NNS ranged_VBD from_IN 50_CD %_NN to_TO 71_CD %_NN for_IN the_DT individual_JJ items_NNS ._.
        Overall_RB ,_, 50_CD %_NN agreed_VBD with_IN 3_CD or_CC more_JJR of_IN the_DT four_CD breast_NN
        cancer_NN screening_NN items_NNS ._.
        Figure_NN 2_CD presents_VBZ the_DT distribution_NN of_IN scores_NNS for_IN the_DT
        summary_NN index_NN ._. While_IN no_DT significant_JJ differences_NNS were_VBD noted_VBN
        by_IN practise_NN location_NN ,_, variation_NN is_VBZ evident_JJ illustrating_VBG
        heterogeneity_NN in_IN responses_NNS ._. As_IN illustrated_VBN in_IN Figure_NN 3_CD ,_, the_DT
        distribution_NN of_IN summary_NN index_NN scores_NNS differed_VBD by_IN clinical_JJ
        group_NN (_( p_NN =_SYM 0_CD ._. 049_CD )_) ._. When_WRB groups_NNS of_IN clinician_NN were_VBD compared_VBN
        separately_RB ,_, the_DT distribution_NN of_IN scores_NNS differed_VBD only_RB for_IN
        physicians_NNS compared_VBN to_TO nurse_NN practitioners_NNS (_( p_NN =_SYM 0_CD ._. 017_CD )_) ._.
        Overall_RB ,_, about_IN one-half_NN of_IN respondents_NNS agreed_VBD with_IN three_CD
        or_CC more_JJR of_IN the_DT four_CD breast_NN cancer_NN screening_NN items_NNS (_( Table_NNP
        2_LS )_) ._. There_EX were_VBD significant_JJ differences_NNS between_IN age_NN tertiles_NNS
        with_IN the_DT <_NN 40_CD year_NN old_JJ group_NN (_( 61_CD %_NN )_) being_VBG more_RBR likely_JJ than_IN
        the_DT >_NN 50_CD year_NN old_JJ group_NN (_( 34_CD %_NN )_) to_TO correctly_RB answer_NN 3_CD or_CC
        more_JJR of_IN these_DT items_NNS ._. Females_NNPS (_( 56_CD %_NN )_) were_VBD more_RBR likely_JJ than_IN
        males_NNS (_( 39_CD %_NN )_) to_TO correctly_RB answer_NN three_CD or_CC more_JJR items_NNS (_( p_NN <_NN
        0_CD ._. 001_CD )_) ._. Differences_NNS were_VBD also_RB observed_VBN when_WRB the_DT summary_NN
        index_NN was_VBD analysed_JJ by_IN practice_NN structure_NN ,_, with_IN only_RB 30_CD ._. 4_LS %_NN
        of_IN solo_NN practitioners_NNS agreeing_VBG with_IN three_CD or_CC more_JJR of_IN the_DT
        four_CD breast_NN screening_NN questions_NNS ._. There_EX were_VBD no_DT significant_JJ
        differences_NNS by_IN geographic_JJ categories_NNS in_IN the_DT summary_NN measure_NN
        or_CC when_WRB individual_JJ questions_NNS on_IN breast_NN cancer_NN screening_NN
        recommendations_NNS were_VBD compared_VBN ._.
        As_IN shown_VBN in_IN Table_NNP 3_CD ,_, approximately_RB 65_CD %_NN of_IN all_DT
        respondents_NNS reported_VBD use_NN of_IN some_DT written_VBN breast_NN cancer_NN
        screening_NN guideline_NN ._. Analysis_NNP of_IN geographic_JJ variations_NNS in_IN
        the_DT reported_VBN use_NN of_IN written_VBN breast_NN cancer_NN guidelines_NNS ,_, after_IN
        adjusting_VBG for_IN age_NN and_CC professional_JJ designation_NN (_( physician_NN ,_,
        nurse_NN practitioner_NN ,_, physician_NN assistant_NN )_) revealed_VBD less_JJR use_NN
        of_IN guidelines_NNS in_IN both_DT suburban_JJ (_( adjusted_VBN OR_NNP =_SYM 0_CD ._. 51_CD ,_, 95_CD %_NN CI_NNP
        0_CD ._. 26_CD -_: 0_CD ._. 98_CD )_) and_CC urban_JJ areas_NNS (_( adjusted_VBN OR_NNP =_SYM 0_CD ._. 56_CD ,_, 95_CD %_NN CI_NNP
        0_CD ._. 33_CD -_: 0_CD ._. 97_CD )_) when_WRB compared_VBN to_TO rural_JJ areas_NNS ._.
      
      
        Discussion_NNP
        While_IN there_EX were_VBD significant_JJ sociodemographic_JJ and_CC
        practice-related_JJ differences_NNS by_IN geographic_JJ regions_NNS ,_, no_DT
        significant_JJ variations_NNS were_VBD observed_VBN in_IN the_DT summary_NN breast_NN
        cancer_NN screening_NN index_NN among_IN urban_JJ ,_, suburban_JJ and_CC rural_JJ
        areas_NNS ._. These_DT results_NNS are_VBP important_JJ in_IN highlighting_VBG
        differences_NNS in_IN how_WRB breast_NN cancer_NN screening_NN is_VBZ approached_VBN ,_,
        with_IN agreement_NN ranging_VBG from_IN 50_CD %_NN to_TO 71_CD %_NN for_IN the_DT individual_JJ
        breast_NN screening_NN items_NNS ._. Moreover_RB ,_, this_DT group_NN of_IN primary_JJ
        care_NN health_NN professionals_NNS demonstrates_VBZ marked_VBN variation_NN in_IN
        approaches_NNS to_TO breast_NN cancer_NN screening_NN since_IN agreement_NN with_IN
        three_CD or_CC more_JJR of_IN the_DT four_CD breast_NN cancer_NN screening_NN statement_NN
        was_VBD just_RB 50_CD %_NN ._. While_IN this_DT variation_NN could_MD be_VB due_JJ to_TO a_DT
        variety_NN of_IN factors_NNS ,_, it_PRP is_VBZ more_RBR likely_JJ that_IN these_DT
        differences_NNS reflect_VBP clinicians_NNS '_POS attempts_NNS to_TO reconcile_VB
        conflicting_JJ recommendations_NNS issued_VBN by_IN various_JJ
        organizations_NNS ._.
        We_PRP defined_VBD one_CD "_'' accepted_VBD "_'' response_NN to_TO each_DT item_NN to_TO serve_VB
        as_IN a_DT basis_NN from_IN which_WDT to_TO examine_VB both_DT dichotomous_JJ and_CC
        polychotomous_JJ responses_NNS ._. While_IN others_NNS might_MD debate_VB which_WDT
        response_NN category_NN is_VBZ "_'' acceptable_JJ "_'' ,_, the_DT fact_NN that_IN responses_NNS
        are_VBP distributed_VBN across_IN several_JJ categories_NNS is_VBZ more_RBR
        noteworthy_JJ ._. That_DT is_VBZ ,_, regardless_RB of_IN the_DT category_NN selected_VBD ,_,
        variation_NN in_IN responses_NNS is_VBZ apparent_JJ ._. It_PRP is_VBZ worth_JJ mentioning_VBG
        that_IN the_DT response_NN option_NN which_WDT we_PRP designated_VBN as_RB the_DT
        "_'' accepted_VBD "_'' answer_NN was_VBD generally_RB observed_VBN to_TO represent_VB the_DT
        modal_NN response_NN ._.
        While_IN a_DT potential_JJ limitation_NN of_IN this_DT study_NN is_VBZ the_DT low_JJ
        response_NN rate_NN (_( 30_CD %_NN )_) ,_, it_PRP is_VBZ comparable_JJ to_TO the_DT lower_JJR range_NN of_IN
        response_NN rates_NNS of_IN health_NN care_NN providers_NNS reported_VBD in_IN a_DT
        review_NN article_NN of_IN this_DT topic_NN [_NN 23_CD ]_NN ._. Our_PRP$ study_NN relied_VBN upon_IN
        a_DT passive_JJ response_NN system_NN without_IN any_DT financial_JJ inducements_NNS
        for_IN completing_VBG a_DT multi-page_JJ mailed_VBN survey_NN ._. The_DT response_NN
        rates_NNS among_IN the_DT geographic_JJ regions_NNS surveyed_VBN were_VBD
        similar_JJ ._.
        It_PRP is_VBZ possible_JJ that_IN clinicians_NNS working_VBG in_IN non-primary_JJ
        care_NN settings_NNS ,_, and_CC specialities_NNS with_IN dual_JJ designations_NNS as_IN
        "_'' primary_JJ care_NN providers_NNS "_'' may_MD have_VB been_VBN less_RBR likely_JJ to_TO
        complete_VB the_DT survey_NN because_IN it_PRP may_MD have_VB been_VBN perceived_VBN as_IN
        outside_IN their_PRP$ usual_JJ scope_NN of_IN practice_NN ._. Also_RB ,_, the_DT length_NN of_IN
        the_DT survey_NN may_MD have_VB contributed_VBN to_TO a_DT reduced_VBN number_NN of_IN
        responses_NNS ._. We_PRP were_VBD not_RB able_JJ to_TO more_RBR fully_RB explore_VB
        sociodemographic_JJ and_CC professional_JJ variations_NNS between_IN
        respondents_NNS and_CC non-respondents_JJ due_NN to_TO limited_JJ baseline_NN
        information_NN beyond_IN mailing_NN addresses_NNS and_CC practice_NN location_NN ._.
        While_IN these_DT limitations_NNS may_MD impact_VB the_DT generalizability_NN of_IN
        our_PRP$ study_NN ,_, the_DT comprehensive_JJ approach_NN of_IN including_VBG
        physicians_NNS ,_, PA_NNP ,_, and_CC NPs_NNP in_IN combination_NN with_IN the_DT large_JJ
        number_NN of_IN respondents_NNS represent_VBP unique_JJ strengths_NNS ._.
        The_DT predominance_NN of_IN women_NNS among_IN urban_JJ and_CC suburban_JJ
        respondents_NNS may_MD be_VB due_JJ to_TO the_DT overrepresentation_NN of_IN nurse_NN
        practitioners_NNS in_IN these_DT groups_NNS ._. Urban_NNP providers_NNS were_VBD more_RBR
        likely_JJ to_TO be_VB involved_VBN in_IN the_DT supervision_NN of_IN trainees_NNS which_WDT
        is_VBZ reflective_JJ of_IN the_DT locations_NNS of_IN clinical_JJ training_NN centers_NNS
        in_IN urban_JJ centers_NNS of_IN Western_NNP New_NNP York_NNP ._. On_IN the_DT other_JJ hand_NN ,_,
        rural_JJ providers_NNS were_VBD more_RBR likely_JJ to_TO report_VB their_PRP$ specialty_NN
        as_IN family_NN or_CC general_JJ practice_NN ._. This_DT is_VBZ consistent_JJ with_IN a_DT
        national_JJ trend_NN of_IN an_DT increasing_VBG physician_NN supply_NN of_IN family_NN
        physicians_NNS /_NN general_JJ practitioners_NNS in_IN rural_JJ communities_NNS [_NN 24_CD
        ]_NN ._. Interestingly_RB ,_, rural_JJ providers_NNS were_VBD also_RB more_RBR likely_JJ to_TO
        be_VB board-certified_JJ than_IN their_PRP$ urban_JJ and_CC suburban_JJ peers_NNS ._. The_DT
        overrepresentation_NN of_IN both_DT family_NN physicians_NNS and_CC nurse_NN
        practitioners_NNS may_MD account_VB for_IN this_DT variation_NN ._.
        Another_DT issue_NN which_WDT is_VBZ not_RB addressed_VBN by_IN these_DT data_NNS is_VBZ
        what_WP clinicians_NNS think_VBP about_IN the_DT guidelines_NNS ._. In_IN other_JJ words_NNS ,_,
        it_PRP is_VBZ not_RB clear_JJ if_IN the_DT clinicians_NNS do_VBP not_RB follow_VB the_DT
        guidelines_NNS because_IN they_PRP are_VBP not_RB familiar_JJ with_IN them_PRP ,_, if_IN they_PRP
        have_VBP reviewed_VBN the_DT guidelines_NNS and_CC do_VBP n't_RB agree_VB with_IN them_PRP ,_, or_CC
        if_IN they_PRP simply_RB find_VBP conflicting_JJ guidelines_NNS to_TO be_VB
        confusing_JJ ._.
        Guidelines_NNS for_IN breast_NN cancer_NN screening_NN are_VBP not_RB uniform_NN
        across_IN organizations_NNS ._. Despite_IN the_DT recent_JJ recommendation_NN
        from_IN the_DT 3_CD rdUSPSTF_NN advising_VBG mammography_NN ,_, with_IN or_CC without_IN
        clinical_JJ breast_NN examination_NN ,_, every_DT 1_CD -_: 2_CD years_NNS for_IN women_NNS ages_NNS
        40_CD years_NNS and_CC older_JJR [_NN 18_CD ]_NN ,_, the_DT issue_NN of_IN mammography_NN among_IN
        women_NNS age_VBP 40_CD -_: 49_CD remains_VBZ under_IN debate_NN ._. The_DT practice_NN of_IN
        obtaining_VBG a_DT baseline_NN mammogram_NN ,_, adopted_VBN by_IN many_JJ primary_JJ
        care_NN physicians_NNS in_IN clinical_JJ practice_NN ,_, does_VBZ not_RB appear_VB in_IN
        the_DT guidelines_NNS of_IN any_DT major_JJ organization_NN ._. The_DT source_NN of_IN
        these_DT guidelines_NNS consulted_VBN for_IN this_DT paper_NN and_CC included_VBD the_DT
        American_NNP Cancer_NNP Society_NNP ,_, the_DT National_NNP Cancer_NNP Institute_NNP ,_,
        specialty_NN societies_NNS and_CC health_NN insurance_NN companies_NNS ._.
      
      
        Conclusions_NNP
        This_DT study_NN suggests_VBZ that_IN primary_JJ care_NN clinicians_NNS ,_,
        including_VBG physicians_NNS ,_, nurse_NN practitioners_NNS ,_, and_CC physician_NN 's_POS
        assistants_NNS ,_, lack_NN a_DT consistent_JJ approach_NN to_TO breast_NN cancer_NN
        screening_NN ._. This_DT lack_NN of_IN agreement_NN does_VBZ not_RB appear_VB to_TO be_VB
        impacted_VBN by_IN geographic_JJ practice_NN location_NN but_CC rather_RB is_VBZ
        likely_JJ a_DT more_RBR global_JJ clinical_JJ issue_NN ._. The_DT implications_NNS of_IN
        this_DT lack_NN of_IN consistency_NN for_IN individual_JJ patients_NNS or_CC groups_NNS
        of_IN patients_NNS are_VBP uncertain_JJ ,_, since_IN it_PRP is_VBZ unclear_JJ how_WRB
        differences_NNS in_IN approaches_NNS to_TO breast_NN cancer_NN screening_NN
        translate_VB into_IN differences_NNS in_IN clinical_JJ practice_NN ._.
        Application_NNP of_IN an_DT industrial_JJ perspective_NN to_TO reduce_VB
        variation_NN would_MD suggest_VB opportunities_NNS to_TO develop_VB a_DT more_RBR
        consistent_JJ approach_NN to_TO how_WRB breast_NN cancer_NN screening_NN is_VBZ
        addressed_VBN in_IN the_DT primary_JJ care_NN setting_NN ._. Development_NNP of_IN an_DT
        evidence-based_JJ ,_, consensus_NN statement_NN regarding_VBG breast_NN cancer_NN
        screening_NN ,_, with_IN broad_JJ endorsement_NN ,_, would_MD support_VB a_DT single_JJ
        set_NN of_IN unambiguous_JJ guidelines_NNS for_IN implementation_NN across_IN
        primary_JJ care_NN settings_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        LS_NNP and_CC MM_NNP were_VBD responsible_JJ for_IN the_DT study_NN concept_NN and_CC
        design_NN ._. MM_NNP ,_, JE_NNP ,_, AM_NNP were_VBD responsible_JJ for_IN the_DT design_NN and_CC
        coordination_NN of_IN the_DT acquisition_NN of_IN data_NNS ._. MM_NNP ,_, SL_NNP ,_, LS_NNP ,_, AS_NNP ,_, AM_NNP
        participated_VBD in_IN the_DT analyses_NNS and_CC interpretation_NN of_IN data_NNS ._.
        SL_NNP ,_, MM_NNP ,_, and_CC LS_NNP drafted_VBD the_DT paper_NN while_IN MM_NNP ,_, SL_NNP ,_, LS_NNP ,_, AS_NNP ,_, AM_NNP ,_,
        JE_NNP were_VBD all_DT involved_VBN in_IN the_DT critical_JJ revisions_NNS ._.
      
    
  
